首页> 外文期刊>Respiratory Medicine Case Reports >Successful treatment of a patient with chyluria due to lymphangioleiomyomatosis using sirolimus
【24h】

Successful treatment of a patient with chyluria due to lymphangioleiomyomatosis using sirolimus

机译:西罗莫司成功治疗因淋巴管平滑肌瘤病而引起的乳糜尿

获取原文
           

摘要

Lymphangioleiomyomatosis (LAM) is a rare and progressive neoplastic disease of young woman, characterized by the proliferation of abnormal smooth muscle-like cells (LAM cells) in the lungs and axial lymphatics. A 44-year-old woman was referred to our hospital because pleural effusion was detected during a health checkup. She had chylothorax, chylous ascites, and chyluria, and her computed tomography scan showed a solid tumor in the pelvis. Surgical biopsy was performed; she was diagnosed as having LAM. We could not control the fluid collection and chyluria using standard medical treatments. Therefore, we chose to administer sirolimus, and her symptoms dramatically improved. The mechanism of chyluria presumably involved LAM cell infiltrates in the ureter via the lymphatic vessel flow, which causes LAM to develop because of ureter wall exposure.
机译:淋巴管平滑肌肌瘤病(LAM)是一种罕见的进行性肿瘤,是年轻女性的一种疾病,其特征是在肺部和轴向淋巴管中增生了异常的平滑肌样细胞(LAM细胞)。一名44岁的妇女因健康检查期间发现了胸腔积液而被转诊到我们医院。她患有乳糜胸,乳突性腹水和乳糜尿,她的计算机断层扫描显示骨盆中有实体瘤。进行手术活检;她被诊断出患有LAM。我们无法使用标准的药物治疗来控制液体的收集和乳糜尿。因此,我们选择服用西罗莫司,她的症状大为改善。乳糜尿的机制可能与LAM细胞通过淋巴管流动渗入输尿管有关,这导致LAM由于输尿管壁暴露而发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号